Cephapirin: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 57: | Line 57: | ||
| StdInChIKey = UQLLWWBDSUHNEB-CZUORRHYSA-N | | StdInChIKey = UQLLWWBDSUHNEB-CZUORRHYSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{si}} | {{si}} | ||
{{cmg}} | {{cmg}} | ||
==Overview== | ==Overview== | ||
'''Cefapirin''' ([[International Nonproprietary Name|INN]], also spelled '''cephapirin''') is an injectable, first-generation [[cephalosporin]] [[antibiotic]]. It is marketed under the trade name Cefadyl. Production for use in humans has been discontinued in the United States.<ref>http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=CEFADYL</ref> | '''Cefapirin''' ([[International Nonproprietary Name|INN]], also spelled '''cephapirin''') is an injectable, first-generation [[cephalosporin]] [[antibiotic]]. It is marketed under the trade name Cefadyl. Production for use in humans has been discontinued in the United States.<ref>http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=CEFADYL</ref> | ||
Revision as of 16:45, 20 April 2015
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| MedlinePlus | a601206 |
| Pregnancy category |
|
| Routes of administration | Intravenous, intramuscular |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C17H17N3O6S2 |
| Molar mass | 423.466 g/mol |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Overview
Cefapirin (INN, also spelled cephapirin) is an injectable, first-generation cephalosporin antibiotic. It is marketed under the trade name Cefadyl. Production for use in humans has been discontinued in the United States.[1]
It also has a role in veterinary medicine as Metricure, an intrauterine preparation, and combined with prednisolone in Mastiplan, an intramammary preparation. Both are licenced in cattle.